Immune Pharmaceuticals Competitors and Similar CompaniesClear all
Immune Pharmaceuticals's competitors and similar companies include Navrogen, Thermosome, BioMimetix and ViaMune.
 Immune Pharmaceuticals Immune Pharmaceuticals applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics. |  Thermosome Thermosome is a biopharmaceutical company developing drug candidates by leveraging its proprietary drug delivery technology, which exploits a mechanism of action called intravascular drug release. |  BioMimetix BioMimetix JV is a company that develops redox-active metalloporphyrin compounds for cancer treatment. | |||
Founding Date | Founding Date 2010 | Founding Date 2017 | Founding Date 2015 | Founding Date 2013 | Founding Date 2011 |
Type | Type Public | Type Private | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations New York, US HQ Jerusalem, IL | Locations US HQ | Locations Planegg, DE HQ | Locations Greenwood Village, US HQ | Locations HQ |
Employees | Employees 722% decrease | Employees 4 | Employees 9 | Employees 10 | Employees N/A |
Valuation ($) | Valuation ($) 1.6 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 8 m | Valuation ($) N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 3.2m (over 6 years ago) | Latest funding round $ 5.2m (about 10 years ago) | Latest funding round $ 2m (almost 15 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 11.7m | Total funding raised $ 3.2m | Total funding raised $ 5.2m | Total funding raised $ 2m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Navrogen
HQ
US
Employees
4
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
View companyThermosome
HQ
Planegg, DE
Employees
9
Thermosome is a biopharmaceutical company developing drug candidates by leveraging its proprietary drug delivery technology, which exploits a mechanism of action called intravascular drug release.
View companyBioMimetix
HQ
Greenwood Village, US
Employees
10
BioMimetix JV is a company that develops redox-active metalloporphyrin compounds for cancer treatment.
View company